Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib in Systemic Mastocytosis Lacking KIT Mutations
NCT01297777Phase 4Completed
- Sponsor
- Hospital Virgen de la Salud
- Start
- Jan 2011
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of imatinib in systemic mastocytosis (SM), sponsored by Hospital Virgen de la Salud. Started Jan 2011; status: completed.
02
Drugs
03
Conditions
systemic mastocytosis (SM)
Beyond the preview
Go deeper on NCT01297777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01297777.